MNOV MediciNova, Inc.
MediciNova, Inc. (MNOV) is expected to report earnings on November 12, 2026, after the market close. The consensus earnings estimate is a loss of $0.06 per share, and the stock has had a Post-Earnings Announcement Drift (PEAD) of -0.8% since its last earnings release on August 13, 2026.
Sign in or subscribe to unlock sentiment, short interest, and technical indicators.
Whisperings™
About MediciNova, Inc.
MediciNova Inc is a development stage biopharmaceutical company. It is engaged in acquiring and developing small molecule therapeutics for the treatment of serious diseases with unmet medical needs.
Sector
Healthcare
Industry
Biotechnology